Pharming Group - Stock Price History | PHGUF
Historical daily share price chart and data for Pharming Group since 1969 adjusted for splits. The latest closing stock price for Pharming Group as of December 31, 1969 is 0.00.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
- The all-time high Pharming Group stock closing price was 0.00 on December 31, 1969.
- The Pharming Group 52-week high stock price is 0.00, which is NAN% above the current share price.
- The Pharming Group 52-week low stock price is 0.00, which is NAN% below the current share price.
- The average Pharming Group stock price for the last 52 weeks is NaN.
|Pharming Group Historical Annual Stock Price Data
||Average Stock Price
||Annual % Change
||Medical - Biomedical and Genetics
Pharming Group NV develops innovative therapeutics for the treatment of genetic disorders, specialty products for surgical indications and nutritional products. The advanced technologies of the Company include innovative and validated platforms for the production of protein therapeutics, technology and processes for the purification and formulation of its products. Its primary product Ruconest (R) is a recombinant human C1 inhibitor approved for the treatment of angioedema attacks in patients with hereditary angioedema in the European Union countries, Norway, Iceland and Liechtenstein. Pharming Group NV is headquartered in Leiden, the Netherlands.